IP Verse

Sun Pharmaceutical Industries Ltd opposition analysis

COMPANY ANALYSIS

Patent:

Grant Date:

Dec 20, 2023

Title:

Extended Release Suspension Compositions

Oppositions:

Patent:

Grant Date:

Feb 23, 2022

Title:

A Stable Parenteral Dosage Form Of Cetrorelix Acetate

Oppositions:

Patent Number	Grant Date	Title	Total Oppositions
EP3137060	Dec 20, 2023	Extended Release Suspension Compositions	1
EP3811927	Feb 23, 2022	A Stable Parenteral Dosage Form Of Cetrorelix Acetate	1

RECKITT BENCKISER HEALTH LIMITED

WEICKMANN & WEICKMANN PARTMBB

Feel free to send us a message here and we will get back to you